Also on the move were Weekend Unlimited, Harvest One Cannabis and Cronos Group
Leronlimab is an antiviral agent candidate with fewer side effects, lower toxicity and less...
The company applies its proprietary C1 gene expression platform to speed up the development of...
It takes medications already available in the US or elsewhere and licenses or acquires the...
New clinical trial data shows that its trial drug Zilosul (iPPS) also reduces knee cartilage...
hVIVO PLC's (LON:HVO) executive chairman Trevor Phillips tells Proactive London's Andrew Scott the business is now better positioned to be profitable next year. The creator of pioneering human disease models based upon viral challenge generated revenues of £5.9mln in the six months ended June...
Health
Ensifentrine offers real benefit to COPD sufferers believes Verona...
Industry & services
Get our market previews and stories before the main networks.
Not just the FTSE. Read about
opportunities from the whole
equities market.
Hear directors at first-hand
or meet them in person at our events.
Watch IPOs and access on the same terms as the institutions.
